Novo Nordisk to present new cardiometabolic disease data, including results from SELECT, at the annual American Heart Association Scientific Sessions
/PRNewswire/ -- Novo Nordisk today announced the upcoming presentation of new data that helps reinforce the company's commitment to driving change and...
Source: prnewswire.com